Wada, H.; Yamamoto, A.; Shiraki, K.; Shimpo, H.
Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on “Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. Diagnostics 2023, 13, 2299”. Diagnostics 2024, 14, 42.
https://doi.org/10.3390/diagnostics14010042
AMA Style
Wada H, Yamamoto A, Shiraki K, Shimpo H.
Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on “Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. Diagnostics 2023, 13, 2299”. Diagnostics. 2024; 14(1):42.
https://doi.org/10.3390/diagnostics14010042
Chicago/Turabian Style
Wada, Hideo, Akitaka Yamamoto, Katsuya Shiraki, and Hideto Shimpo.
2024. "Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on “Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. Diagnostics 2023, 13, 2299”" Diagnostics 14, no. 1: 42.
https://doi.org/10.3390/diagnostics14010042
APA Style
Wada, H., Yamamoto, A., Shiraki, K., & Shimpo, H.
(2024). Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on “Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. Diagnostics 2023, 13, 2299”. Diagnostics, 14(1), 42.
https://doi.org/10.3390/diagnostics14010042
